A panel of blood biomarkers discovered by researchers at the University of California, Davis (UC Davis) MIND Institute and NeuroPointDX could create a new test to detect autism spectrum disorder (ASD) in certain children.
As part of the Children’s Autism Metabolome Project (CAMP), the team investigated the role of metabolome molecules in genetic and environmental factors associated with autism development.